Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5701–5750 of 75406
On April 28, 2025, the board of directors (the “Board”) of Plum Acquisition Corp. IV (the “Company”) appointed Mr. Aidin Aghamiri to serve as an independent director of the Company, effective April 25, 2025.
Michael A. Hug, the Company's current CFO, will step down from that role on the Transition Date and continue as an employee of a subsidiary of the Company until his previously announced retirement on June 9, 2025
appointed Erik D. Hoag as Chief Financial Officer ("CFO") of the Company, effective May 19, 2025
announcing the hiring of Mr. Jeffrey (Jeff) B. Cotten as President and Chief Executive Officer, effective June 2, 2025.
Mr. Reiner also expects to resign from the Company's Board of Directors on such date.
Upon commencing employment and taking office as President and Chief Executive Officer, Mr. Cotten will join the Company's Board of Directors as a Class III director with an initial term expiring at the 2028 annual meeting of stockholders.
the Company's current President and Chief Executive Officer, Andres Reiner, will be retiring from such offices effective as of Mr. Cotten's start date.
On April 25, 2025, Judd Merrill notified us that he intends to resign as our Chief Financial Officer effective on May 16, 2025
the Company has accepted the resignation of its Board member and Vice President of Operations, Mohammad Sadrolashrafi, as well as appointing Robert James Kane as a new director and Business Development Officer.
the Company has accepted the resignation of its Board member and Vice President of Operations, Mohammad Sadrolashrafi, as well as appointing Robert James Kane as a new director and Business Development Officer.
On April 29, 2025, Mark Jenkins, a Class II director of Carlyle Secured Lending, Inc. (the “Company”) and a Managing Director of The Carlyle Group, Inc. (“Carlyle”), informed the Company that he is resigning from the Board of Directors of the Company (the “Board”), effective April 29, 2025.
On April 29, 2025, the Board appointed Thomas Hennigan as a Class II director to fill the vacancy created by Mr. Jenkins’ resignation.
On May 1, 2025, Murphy USA Inc. ("Murphy USA") issued a news release announcing the appointment on that date of David C. Haley to Murphy USA's Board of Directors.
In connection with Ms. Treadway’s termination effective as of April 2, 2025 (the “Treadway Separation Date”), the Company and Ms. Treadway entered into a separation agreement effective as of May 1, 2025 (the “Treadway Separation Agreement”).
appointed Neil J. Gallagher, M.D., Ph.D. to the Board, effective May 1, 2025.
appointed Stuart Duty to the Board, effective May 1, 2025.
Daniel C. Reardon, was appointed by the Board to fill the vacancy resulting from the increase in the size of the Board.
On April 30, 2025, Steven Sugarman was appointed President, Chief Executive Officer and Director of Patriot Bank, N.A.
Angie Miranda was appointed Executive Vice President, Chief Risk Officer of the Bank, to be effective as of May 6, 2025.
On April 25, 2025, Andrew Dahlem resigned from the Board of Directors of Syra Health Corp. (the “Company”) for personal reasons.
On May 1, 2025, upon recommendation of the Nominating and Corporate Governance Committee, the Board of Directors (the “Board”) of Vaxcyte, Inc. (the “Company”) appointed Dr. Olivier Brandicourt to the Board as a Class III director, which appointment became effective immediately.
the election of Mr. Bruce D. Hoechner as Chair of the Board
the election of Mr. David H. Li and Mr. F. David Segal to fill the vacancies created by the expansion of the Board
the election of Mr. David H. Li and Mr. F. David Segal to fill the vacancies created by the expansion of the Board
Mr. Terence Wise notified the Company of his intention to resign from his position as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors.
On April 29, 2025, Mark Jenkins, a Class II director of Carlyle Credit Solutions, Inc. (the “Company”) and a Managing Director of The Carlyle Group, Inc. (“Carlyle”), informed the Company that he is resigning from the Board of Directors of the Company (the “Board”), effective April 29, 2025.
On April 29, 2025, the Board appointed Thomas Hennigan as a Class II director to fill the vacancy created by Mr. Jenkins’ resignation.
On April 30, 2025, in connection with the IPO, Sam Lynn, Darla K. Anderson and Constance K. Weaver were appointed to the board of directors of the Company.
On April 30, 2025, in connection with the IPO, Sam Lynn, Darla K. Anderson and Constance K. Weaver were appointed to the board of directors of the Company.
On April 30, 2025, in connection with the IPO, Sam Lynn, Darla K. Anderson and Constance K. Weaver were appointed to the board of directors of the Company.
Nancy Avila's term as a director ended on April 29, 2025.
On April 25, 2025, Simon M. Bates informed DMC Global Inc. ("DMC") of his decision to resign from the Board of Directors of DMC (the "Board") effective April 30, 2025
On April 28, 2025, Christopher Schell, Executive Vice President, Chief Commercial Officer, and General Manager of Sales, Marketing and Communications, notified Intel of his decision to resign, effective as of June 30, 2025, in order to pursue another career opportunity.
On April 30, 2025, State Street Corporation (“State Street”) announced that it is appointing John F. Woods to serve as Chief Financial Officer (“CFO”), effective no later than August 25, 2025.
Upon Mr. Woods assuming the CFO role, Mark R. Keating will cease serving as interim CFO and continue with his other current areas of responsibility.
D. Adamczyk notified the Company that he intends to retire from the Company’s Board of Directors in connection with an announcement on April 23 rd that he will join Goldman Sachs as a Partner.
to appoint Barbara Carbone to fill the new director position, with effect from May 1, 2025
the role then held by Annie Bloomquist , Executive Vice President and Chief Innovation Officer was eliminated and she ceased serving in that role
the Board determined that Matthew Moschner, who currently serves as the Company’s President and Chief Operating Officer, will succeed Mr. Willett as CEO
appointed Mr. Moschner as a director of the Company, effective as of the Transition Date
Robert Willett advised the Company that he will retire as Chief Executive Officer (“CEO”) of the Company, effective June 27, 2025
the Company and its Executive Vice President and Chief Financial Officer, Neill P. Reynolds, have agreed that he will be departing the Company effective May 30, 2025.
The Company onboards its new Chief Executive Officer, Robert Feurle, on May 1, 2025.
On April 28, 2025, Peter J. Hadley was appointed Chief Financial Officer (“CFO”) of Automatic Data Processing, Inc. (the “Company”), effective July 1, 2025.
Mr. Hadley, age 52, will succeed Don McGuire who will be stepping down from this role as of June 30, 2025, and will continue to serve as a corporate officer of the Company during a transition period through September 30, 2025.
On April 24, 2025, Laureen DeBuono notified the Board of Directors (“Board”) of Rani Therapeutics Holdings, Inc. (the “Company”) that she has decided to retire from the Board effective immediately.
On April 30, 2025, the Company appointed Sean Fukumura, age 42, to serve as the Company’s Chief Accounting Officer, effective May 5, 2025.
On April 29, 2025, Timothy Dieffenbacher notified FrontView REIT, Inc. (the “Company”) of his decision to resign from his role as Chief Financial Officer, Treasurer, and Secretary of the Company, effective May 5, 2025.
On April 30, 2025, the Company appointed Randall Starr, age 47, to serve as the Company’s Chief Financial Officer, Treasurer, and Secretary, effective May 5, 2025.
On April 25, 2025, the Company and Steve Priest, the Company’s current Senior Vice President and Chief Financial Officer, determined that Mr. Priest will step down as Senior Vice President and Chief Financial Officer of the Company, effective May 11, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.